FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

35410311000001106: RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Jun 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1266041000001112 RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1266051000001110 RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) Is a Tocilizumab 162mg/0.9ml solution for injection pre-filled disposable devices true Inferred relationship Existential restriction modifier
RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) Has active ingredient Tocilizumab true Inferred relationship Existential restriction modifier
RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) Has specific active ingredient Tocilizumab true Inferred relationship Existential restriction modifier
RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) Is a RoActemra true Inferred relationship Existential restriction modifier
RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) 4 pre-filled disposable injection Has AMP True RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start